• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Acetylon Pharmaceuticals

edit

Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Milestones

edit

• 
  Acetylon Pharmaceuticals added Walter C. Ogier as President.
  Posted 10/16/09 at 6:18pm
• 
  Acetylon Pharmaceuticals received $15M in Unattributed funding. (2/9/12)
  Posted 2/9/12 at 6:00am via yahoo.com
• 
  Acetylon Pharmaceuticals received $14.6M in Series B funding. (6/29/11)
  Posted 6/29/11 at 6:21pm via masshightech.com
• 
  Acetylon Pharmaceuticals received $12.4M in Series B funding. (2/22/11)
  Posted 2/22/11 at 7:29pm via masshightech.com
• 
  Acetylon Pharmaceuticals received $2M in Series A funding. (1/8/10)
  Posted 1/8/10 at 8:13pm via finsmes.com
• 
  Acetylon Pharmaceuticals received $7.25M in Series A funding. (8/1/09)
  Posted 10/16/09 at 6:18pm via onbiovc.com
• 
  Acetylon Pharmaceuticals — moving from its Albany Street location in Boston to the Seaport Center near the South Boston waterfront. (7/5/11)
  Posted 7/5/11 at 9:31am via masshightech.com
• 
  Acetylon Pharmaceuticals — announces two new members to scientific advisory board. (4/25/11)
  Posted 4/26/11 at 3:45am via masshightech.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/9/10

Sources

1. Acetylon Pharmaceuticals, Inc.: Series A $7.2M (onbiovc.com) [edit]
2. Acetylon Pharmaceuticals Raises $2M (finsmes.com) [edit]
3. Acetylon finds $12.4 million Series B funding (masshightech.com) [edit]
4. Acetylon closes Series B round at $27M (masshightech.com) [edit]
5. Acetylon Announces $15 Million Strategic Equity Investment by Celgene Corporation (finance.yahoo.com) [edit]
6. Acetylon Pharmaceuticals expands advisory board (masshightech.com) [edit]
7. Acetylon moving to Boston’s Seaport Center (masshightech.com) [edit]